inHEART: Funding, Investors & Team (Oct 2026)
inHEART is a spin-off from IHU Liryc and Inria, two top-tier research centers respectively in cardiac electrophysiology and digital science and technology, that develops software solutions for medical image analysis and cardiac modeling in heart rhythm disorders. inHEART vision is to make the bridge between radiology and cardiology to become a worldwide leader in image-guided diagnosis, therapy planning and navigation software solutions for heart rhythm disorders.
inHEART has raised $3.7M across 1 funding round on record, the most recent an undisclosed round of $3.7M announced in Jul 2020.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
inHEART Company Profile and Key Stats
Latest funding round on record: Jul 2020.
inHEART Funding Rounds
inHEART Founders and Leadership Team
No contact details are on record for this team yet.
inHEART Funding Compared to Other Biotechnology Startups
inHEART's latest round of $3.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like inHEART in Biotechnology and Pessac
Companies Similar to inHEART
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
inHEART Funding FAQs
What does inHEART do?
inHEART is a spin-off from IHU Liryc and Inria, two top-tier research centers respectively in cardiac electrophysiology and digital science and technology, that develops software solutions for medical image analysis and cardiac modeling in heart rhythm disorders. inHEART vision is to make the bridge between radiology and cardiology to become a worldwide leader in image-guided diagnosis, therapy planning and navigation software solutions for heart rhythm disorders.
How much funding has inHEART raised?
inHEART has raised $3.7M across 1 round on record. The most recent is an undisclosed round of $3.7M announced in Jul 2020.
When did inHEART last raise funding?
inHEART's most recent funding round on record is an undisclosed round of $3.7M, announced in Jul 2020.
Who is the CEO of inHEART?
Jean Peyrat is listed as CEO at inHEART.
Where is inHEART headquartered?
inHEART is based in Pessac, Aquitaine, France.
How many employees does inHEART have?
inHEART is in the 11-50 employee band.
How does inHEART's funding compare to other Biotechnology startups?
inHEART's latest round of $3.7M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's inHEART Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for inHEART is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.